This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022 | In-Person + DigitalHynes Convention Center, Boston

Yvonne Duckworth, PE
Senior Automation Engineer at CRB


Yvonne Duckworth, PE is a registered Automation Engineer at CRB with 30+ years of experience working in the pharmaceutical and biotech industries. Ms. Duckworth is also an Industry 4.0 subject matter expert (SME) providing Digitalization consulting for the pharma and biotech industries. With a strong background in both technical design and project management, her areas of expertise include instrumentation design, process control system design including PLC and DCS based platforms, network infrastructure design, control system programming, commissioning, validation and construction, start-up support activities, as well as Industry 4.0 and Digitalization initiatives.

Ms. Duckworth has spoken at multiple ISPE and Interphex events, both nationally and internationally, featuring Automation and Digitalization.  She has also presented as a guest speaker for local universities specializing in biotechnology.  Ms. Duckworth has written multiple magazine articles featuring Pharma 4.0/Industry 4.0.  Ms. Duckworth is a committee member and track leader for the upcoming ISPE Pharma 4.0 and Annex 1 conference to be held in Vienna this December. Ms. Duckworth is a Board Member of the Oligo Advisory Board sponsored by Asahi Kasei.

Ms. Duckworth has a Bachelor of Science in Electrical Engineering from Widener University and a Master of Business Administration from Rider University. She is an active member of the International Society for Pharmaceutical Engineering (ISPE), Women in Pharma (WIP), International Society of Automation (ISA), and Women in Bio (WIB).  She is also a co-chair of the ISPE Pharma 4.0 Holistic Control Strategy Special Interest Group (SIG) as well as the Impact & Maturity Special Interest Group (SIG).

Agenda Sessions

  • Elements of Effective Digital Technologies Coupled with a Robust Automation Platform in the Pharma 4.0 Journey